DG DISPATCH - RSNA: Cryoablation Highly Effective For Renal Cell Carcinoma
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




DG DISPATCH - RSNA: Cryoablation Highly Effective For Renal Cell Carcinoma

By W. A. Thomasson, PhD
Special to DG News

CHICAGO, IL -- December 1, 2000 -- Cryoablation, a procedure readily visualized in real time under magnetic resonance imaging (MRI), is highly effective for destroying renal cell carcinomas. The procedure also preserves renal function and has few complications.

P. E. Sewell, Jr., MD, of the University of Mississippi Medical Center (Jackson) presented these findings yesterday (Nov. 30) at the annual meeting of the Radiological Society of North America, in Chicago, Illinois.

Dr. Sewell’s report covered 36 patients with 38 exfoliative, parenchymal, hilar or mixed tumors that were less than 12 cm in diameter. Thirty-four patients were treated under general anesthesia, primarily to improve imaging and to minimize position-associated discomfort.

Between one and four cryoprobes were placed and used to produce three freeze-thaw cycles with a target temperature of -4 degrees Celsius for all visible tumor. Since frozen water is highly visible on MRI, with a clear boundary between frozen and unfrozen areas, the operator can easily follow growth of the freeze zone and verify that it covers the entire tumor.

Thirty-one of the 36 patients were found to be apparently tumor-free after a single treatment. The remaining five patients were retreated successfully. Furthermore, there have been no initial treatment failures since Dr. Sewell and his colleague, W. B. Shingleton, MD, switched to a different type of probe.

Creatine levels did not change from those measured preoperatively, except in one patient who had a stable improvement. The only complications have been four cases of gross hematuria, all of which resolved spontaneously, and one wound abscess. There have been no fistulae or instances of damage to the collecting system.

These are very exciting results, Dr. Sewell said, raising the possibility that physicians may be able to offer patients who are not surgical candidates the same opportunity for cure as is available to those who undergo surgery.

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities